Although the medical relevance of your aforementioned cardiovascular chance factor alterations by tirzepatide are going to be assessed while in the planned cardiovascular final result examine SURPASS-CVOT ( "style":"clinical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-anal